We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bristol-Myers Squibb, Sanofi-Aventis Challenge Apotex's Plavix
Sanofi-aventis and Bristol-Myers Squibb (BMS) are trying to stop Apotex from selling its generic version of their blockbuster blood thinner Plavix by seeking a preliminary injunction in a U.S. federal court, but a patent agreement they signed with Apotex may prevent them from getting it, according to one legal expert.